Why the study?
Does chronic tempol ingestion improve skeletal muscle perfusion and microvessel density in obese Zucker rats?
Population
12-week-old obese Zucker rats (OZR) and lean Zucker rats (LZR)
Comparison
4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl… vs Untreated control conditions
Design
Preclinical
Follow-up
approximately 4 weeks
Authors
Loading...
No clinical translation yet; extends preclinical evidence for tempol in metabolic syndrome microvascular dysfunction.
Does chronic tempol ingestion improve skeletal muscle perfusion and microvessel density in obese Zucker rats?
Chronic reductions in nitric oxide bioavailability contribute to skeletal muscle microvessel rarefaction and impaired perfusion in a rat model of metabolic syndrome.
Jefferson C. Frisbee (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: